EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

m6A RNA Modification: Technologies Behind Future Anti-Cancer Therapy

Kristina Shpiliukova iD, Artyom Kachanov iD, Sergey Brezgin iD, Vladimir Chulanov iD, Alexander Ivanov iD, Dmitry Kostyushev iD, Anastasiya Kostyusheva

Molecules · 2025

DOI: 10.3390/molecules30204091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Kristina Shpiliukova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, Sechenov University, Moscow 119991, Russia. Hauptthemen laut MEDLINE: Adenosine, Neoplasms, Antineoplastic Agents, RNA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation (Federal scientific and technical program for the development of genetic technologies for 20…, Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N6-methyladenosine (m6A) modifications are among the most prevalent epigenetic marks in eukaryotic RNAs, regulating both coding and non-coding RNAs and playing a pivotal role in RNA metabolism. Given their widespread influence, m6A modifications are deeply implicated in the pathogenesis of various cancers, including highly aggressive malignancies such as lung cancer, melanoma, and liver cancer. Dysregulation of m6A dynamics—marked by an imbalance in methylation and demethylation—can drive tumor progression, enhance metastatic potential, increase aggressiveness, and promote drug resistance, while also exerting context-dependent tumor-suppressive effects. Given this dual role, precise modulation of m6A levels and the activity of its regulatory enzymes (writers, erasers, and readers) represent a promising therapeutic avenue. In this review, we highlight recent advances in targeting m6A machinery, including small-molecule inhibitors, antisense oligonucleotides, and CRISPR/Cas-based editing tools, capable of both writing and erasing m6A marks and altering m6A methylation sites per se. By evaluating these strategies, we aim to identify the most effective approaches for restoring physiological m6A homeostasis or for strategically manipulating the m6A machinery for therapeutic benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineNeoplasmsAntineoplastic AgentsRNARNA Processing, Post-TranscriptionalHumansMethylationAnimalsEpigenesis, GeneticRNA Methylation

Stichwörter der Autor:innen

NGSgenetic technologiesmetastasisoutcomestargeted therapy

Substanzen

AdenosineN-methyladenosineAntineoplastic AgentsRNA

Autor:innen und Institutionen

  • Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, Sechenov University, Moscow 119991, Russia.
  • Center for Precision Genetic Technologies for Medicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow 119991, Russia.
  • Laboratory of Experimental Therapy of Infectious Diseases, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, Sechenov University, Moscow 119435, Russia.
  • Department of Infectious Diseases, Sechenov University, Moscow 119435, Russia.
  • Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow 119192, Russia.

ORCID-Profile: Kristina Shpiliukova, Artyom Kachanov, Sergey Brezgin, Vladimir Chulanov, Alexander Ivanov, Dmitry Kostyushev

Förderung

  • Ministry of Science and Higher Education of the Russian Federation (Federal scientific and technical program for the development of genetic technologies for 20…
  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Shpiliukova, K., Kachanov, A., Brezgin, S., Chulanov, V., Ivanov, A., Kostyushev, D., & Kostyusheva, A. (2025). m6A RNA Modification: Technologies Behind Future Anti-Cancer Therapy. Molecules. https://doi.org/10.3390/molecules30204091

Vancouver

Shpiliukova K, Kachanov A, Brezgin S, Chulanov V, Ivanov A, Kostyushev D, et al. m6A RNA Modification: Technologies Behind Future Anti-Cancer Therapy. Molecules. 2025. doi:10.3390/molecules30204091

BibTeX
@article{Shpiliukova2025,
  author = {Shpiliukova, Kristina and Kachanov, Artyom and Brezgin, Sergey and Chulanov, Vladimir and Ivanov, Alexander and Kostyushev, Dmitry and Kostyusheva, Anastasiya},
  title = {m6A RNA Modification: Technologies Behind Future Anti-Cancer Therapy},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30204091}
}
Kostenlos starten →